{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:50Z","timestamp":1786987730154,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM104037"],"award-info":[{"award-number":["R01GM104037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VA grant","award":["BX002741"],"award-info":[{"award-number":["BX002741"]}]},{"name":"Rutgers Busch grant"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.dld.2018.04.009","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T13:27:58Z","timestamp":1524490078000},"page":"1068-1075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice"],"prefix":"10.1016","volume":"50","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin D.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rizzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica D.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Horng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2018.04.009_bib0005","first-page":"161","article-title":"Lipid peroxidation in ethanol poisoning: a critical reconsideration","volume":"20","author":"Dianzani","year":"1985","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2018.04.009_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(87)80003-X","article-title":"Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess","volume":"4","author":"Bode","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.04.009_bib0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0378-4274(92)90086-Y","article-title":"Ethanol toxicity and oxidative stress","volume":"63","author":"Bondy","year":"1992","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.dld.2018.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.04.009_bib0025","first-page":"113","article-title":"Current management of alcoholic hepatitis and future therapies","volume":"4","author":"Saberi","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.dld.2018.04.009_bib0030","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.3748\/wjg.v20.i36.12908","article-title":"New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases","volume":"20","author":"Williams","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2018.04.009_bib0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.dld.2018.04.009_bib0040","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.dld.2018.04.009_bib0045","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.04.009_bib0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.04.009_bib0055","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.04.009_bib0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2008.12.117","article-title":"Suppression of interleukin-6-induced C-reactive protein expression by FXR agonists","volume":"379","author":"Zhang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2018.04.009_bib0065","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1210\/me.2010-0117","article-title":"Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity","volume":"24","author":"Lee","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.dld.2018.04.009_bib0070","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/me.2009-0286","article-title":"FXR regulates liver repair after CCl4-induced toxic injury","volume":"24","author":"Meng","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.dld.2018.04.009_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/754067","article-title":"Bile Acid signaling in liver metabolism and diseases","volume":"2012","author":"Li","year":"2012","journal-title":"J Lipids"},{"key":"10.1016\/j.dld.2018.04.009_bib0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.apsb.2016.07.008","article-title":"Fatty liver diseases, bile acids, and FXR","volume":"6","author":"Zhu","year":"2016","journal-title":"Acta Pharm Sinica B"},{"key":"10.1016\/j.dld.2018.04.009_bib0085","doi-asserted-by":"crossref","first-page":"G295","DOI":"10.1152\/ajpgi.00134.2015","article-title":"Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis","volume":"310","author":"Kong","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2018.04.009_bib0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cbi.2014.03.014","article-title":"The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice","volume":"217","author":"Livero","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.dld.2018.04.009_bib0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","article-title":"Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dld.2018.04.009_bib0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.dld.2018.04.009_bib0105","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dld.2018.04.009_bib0110","doi-asserted-by":"crossref","first-page":"G32","DOI":"10.1152\/ajpgi.00024.2012","article-title":"Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury","volume":"303","author":"Wang","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2018.04.009_bib0115","first-page":"G605","article-title":"Alcoholic liver injury involves activation of Kupffer cells by endotoxin","volume":"275","author":"Thurman","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.dld.2018.04.009_bib0120","article-title":"Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice","author":"Hartmann","year":"2017","journal-title":"Hepatology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818307060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818307060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T09:45:26Z","timestamp":1541151926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818307060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1590865818307060"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.04.009","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}